单位(元)申万菱信中证申万医药生物指数A(163118)资产负债表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
资产 |
银行存款 |
17,507,855 |
19,033,394 |
19,762,504 |
18,413,739 |
结算备付金 |
3,384 |
24,053 |
28,303 |
43,917 |
存出保证金 |
7,369 |
11,886 |
15,206 |
19,661 |
交易性金融资产 |
250,090,241 |
260,364,383 |
275,391,958 |
259,564,935 |
其中:股票投资 |
250,090,241 |
260,364,383 |
275,391,958 |
259,564,935 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
70,979 |
6,409 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
273,583 |
442,266 |
632,964 |
874,328 |
其他资产 |
- |
- |
- |
- |
资产总计 |
267,882,432 |
279,875,982 |
295,901,914 |
278,922,988 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
371,609 |
- |
- |
应付赎回款 |
562,657 |
571,467 |
1,436,794 |
1,220,991 |
应付管理人报酬 |
227,208 |
231,278 |
247,083 |
209,682 |
应付托管费 |
45,441 |
50,881 |
54,358 |
46,130 |
应付销售服务费 |
9,185 |
9,465 |
6,308 |
1,133 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
232,323 |
167,033 |
244,084 |
148,903 |
负债合计 |
1,076,813 |
1,401,734 |
1,988,628 |
1,626,839 |
所有者权益 |
实收基金 |
254,249,064 |
254,703,265 |
242,095,485 |
199,425,527 |
未分配利润 |
12,556,555 |
23,770,983 |
51,817,801 |
77,870,622 |
所有者权益合计 |
266,805,618 |
278,474,248 |
293,913,286 |
277,296,149 |
负债和所有者权益总计 |
267,882,432 |
279,875,982 |
295,901,914 |
278,922,988 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。